Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 76/100 | DilutionWatch score record |
| Shares Outstanding | 3.46M | Verified float table or market cache |
| Public Float | 935.4K | Verified float table or market cache |
| Market Cap | $1.43M | Market data cache |
| Cash Runway | 12.6 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | $2.31M | SEC-derived dilution fields |
| Outstanding Warrants | 6.06M | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 6.
Recent SEC source mix: 424B5 1, 8-K 3, S-1 1, XBRL 1.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
APVO SEC Filing Activity — Last 12 Months
Shares outstanding reported by APVO on the cover page of its latest 10-K/10-Q: 3.46M as of November 16, 2026.
DilutionWatch recorded 2 registration or prospectus documents for APVO (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| S-1 | registration statement (IPO / follow-on) | 1 | Nov 20, 2026 |
| 424B5 | prospectus supplement (ATM / shelf takedown) | 1 | Oct 30, 2026 |
| 8-K | current report (material event) | 6 | Nov 16, 2026 |
| 10-Q | quarterly report | 1 | Nov 16, 2026 |
| SC 13G/A | amended passive >5% holder filing | 2 | Nov 16, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual APVO Dilution Snapshot
Aptevo Therapeutics Inc. (APVO) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: November 20, 2026.
- Stored ATM program remaining capacity: $2.3M.
- Stored outstanding warrants: 6.1M.
- Recent SEC activity tracked for APVO: S-1 on 2026-11-20; xbrl on 2026-11-16; 8-K on 2026-11-12.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
APVO's DilutionScore is currently 76/100 (Critical risk), with 2 score changes tracked over 89 days. The score improved from 63/100 (High risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Nov 20, 2026 | 76/100 | CRITICAL | 1 day |
| Oct 05 – Nov 19, 2026 | 63/100 | HIGH | 46 days |
| Aug 24 – Oct 04, 2026 | 41/100 | MEDIUM | 42 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
APVO shares outstanding have increased 92.3% from 1.80M (Nov 2026) to 3.46M (Nov 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| Nov 21, 2026 | 3.46M | 935.4K | — |
| Nov 17, 2026 | 3.46M | 935.4K | — |
| Nov 10, 2026 | 1.80M | 935.4K | — |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — CRITICAL Risk
Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.